Your browser doesn't support javascript.
loading
Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time: An IMI-DIRECT study.
Obura, M; Beulens, J W J; Slieker, R; Koopman, A D M; Hoekstra, T; Nijpels, G; Elders, P; Dekker, J M; Koivula, R W; Kurbasic, A; Laakso, M; Hansen, T H; Ridderstråle, M; Hansen, T; Pavo, I; Forgie, I; Jablonka, B; Ruetten, H; Mari, A; McCarthy, M I; Walker, M; McDonald, T J; Perry, M H; Pearson, E R; Franks, P W; 't Hart, L M; Rutters, F.
Afiliação
  • Obura M; Epidemiology and Data Science, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Beulens JWJ; Epidemiology and Data Science, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Slieker R; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Koopman ADM; Epidemiology and Data Science, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Hoekstra T; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Nijpels G; Epidemiology and Data Science, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Elders P; Epidemiology and Data Science, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Dekker JM; Department of Health Sciences, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands.
  • Koivula RW; Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, The Netherlands.
  • Kurbasic A; Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, The Netherlands.
  • Laakso M; Epidemiology and Data Science, Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Hansen TH; Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmö, Sweden.
  • Ridderstråle M; Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Oxford, UK.
  • Hansen T; Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmö, Sweden.
  • Pavo I; Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Finland.
  • Forgie I; The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Jablonka B; Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark.
  • Ruetten H; The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mari A; The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • McCarthy MI; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Walker M; Eli Lilly Regional Operations GmbH, Vienna, Austria.
  • McDonald TJ; Division of Cardiovascular & Diabetes Medicine, Medical Research Institute, University of Dundee, Dundee, UK.
  • Perry MH; Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.
  • Pearson ER; Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.
  • Franks PW; Institute of Biomedical Engineering, National Research Council, Padova, Italy.
  • 't Hart LM; Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Oxford, UK.
  • Rutters F; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Diabet Med ; 38(2): e14428, 2021 02.
Article em En | MEDLINE | ID: mdl-33067862

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Peptídeo C / Resistência à Insulina / Intolerância à Glucose / Diabetes Mellitus Tipo 2 / Secreção de Insulina / Insulina Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Peptídeo C / Resistência à Insulina / Intolerância à Glucose / Diabetes Mellitus Tipo 2 / Secreção de Insulina / Insulina Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article